The ONS Podcast

“Don’t be afraid of applying, even if you’ve never planned a conference before, and you think, ‘Well, I have no idea what I’m doing.’ You probably know more than you think you do. You probably have m…

“The nurse’s role in monitoring the lab values really depends on the clinics you're working at, but really when our patients are receiving treatment, especially in the infusion center, the nurses sho…

“Although the patient is spending a little less time in the clinic, the administration actually requires the nurse to be at the chairside the entire time. This has allowed nurses to spend potential…

“The gravity of the responsibility was realized when you walked into the boardroom and you’re there to make decisions, and the perspective you have to take shifts. Of course, I bring to the table my…

“Under normal conditions, EGFR [epidermal growth factor receptor] is in an auto-inhibited state. And it’s only when it’s needed that it’s upregulated. But when you have cancers that there is either …

Episode 335: Ultrasound-Guided IV Placement in the Oncology Setting

“Much like many experienced oncology nurses, I learned how to do IVs with palpation. I got really good at it. And so I thought,…

“There is an old saying that if you ignore your teeth, they’ll go away. I think that’s a true, true statement. People may think they can get away without daily hygiene. I think that’s kind of impor…

“CDK4/6 inhibition is considered to be a milestone in the realm of targeted breast cancer therapy. The combination of CDK4/6 inhibitors with the endocrine therapy has really emerged as the foremost t…

“Nurses really are the professionals who educate how to take these medicines, why we use multimodal therapies, why it isn’t medicine alone—helping patients to understand that pain is a biopsychosocia…

“One of the biggest things we’ve heard in nursing school and we continue to hear in practice is it takes anywhere from 15 to 20 years for knowledge in the literature to reach practice in a significan…

“The reality is that we are responsible for creating a culture of safety together for everybody in the clinical area. We have to think not only about ourselves and our personal risk, but how exposure…

“One of the things that’s really challenging with these BRAF inhibitors, plus MEK inhibitors, is that there’s a huge scope of potential toxicity, and they’re not all going to happen. So I think that …

“Supportive personnel have a great ability to connect with patients and peers, and if that’s utilized effectively, it will make a great, great, great, great place to work, with great people to work w…

“It’s not often in life that you find something that gives you this feeling, but I’m really so fortunate to have found mine, and I know this is only just the beginning, and I cannot wait to see what …

“One of the big misconceptions is that this is just a quick shot. And this is a patient’s treatment regimen. So, it is not just a quick shot. It is treatment, and we need to get it where it is suppos…

“These evidence-based standards provide a great framework for best practice in cancer care and the 2016 publication is extensively referenced. However, patient care mistakes and medication errors sti…

“A lot of the efforts have been made to improve the patient experience for these treatments, as they can be given for years at a time. For example, when leuprolide debuted way back in 1985, it was a…

“Instead of creating silos, how can we work together, create networks, and elaborate more in the future? Because we have such a robust wealth of knowledge and expertise, that ONS is very good at hel…

“I think poor discharge planning is that top contributor [to readmission]. And by that, I mean discharge planning that doesn’t assess a patient’s educational level, their support at home, what resou…

“I think we’re in a scientific golden age for prostate cancer and probably cancer as a whole, but we’re talking about prostate cancer today. So I’m excited to be sitting on the front lines, seeing t…